AZTR News and Press, Azitra Inc From 12/17/25

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American PR Newswire BRANFORD, Conn. , Dec. 17, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapi...

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules PR Newswire BRANFORD, Conn. , Nov. 24, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on dev...

2025-11-13 04:23:44 ET More on Azitra Azitra receives notice of non-compliance from NYSE American Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alp...

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates PR Newswire BRANFORD, Conn. , Nov. 12, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision ...

2025-11-07 06:05:51 ET More on Azitra Azitra receives notice of non-compliance from NYSE American Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alp...

Azitra, Inc. Addresses False Report Regarding Sale of Securities PR Newswire BRANFORD, Conn. , Nov. 7, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology...

2025-10-20 13:20:39 ET DENVER, Colo., Oct 20, 2025 ( 247marketnews.com )- Wall Street is buzzing this Friday as a mix of innovative biotech breakthroughs, next-gen partnerships, and surprising revenue beats drive a midday rally across select sectors. Here’s your editorial roundup...

A look at the top 10 most actives in the United States Beyond Meat Inc. (BYND) rose 46.2% to $0.9441 on volume of 248,997,232 shares Adaptimmune Therapeutics plc (ADAP) fell 70.1% to $0.0598 on volume of 138,511,757 shares Replimune Group Inc. (REPL) rose 101.3% to $9.06 on volume of 63,729...

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris PR Newswire ATR-01, which uses a filaggrin-secreting strain of S. epidermidis , is in preclinical development for ichthyosis vulgaris Preclinical data show production of ...

2025-10-03 16:58:14 ET More on Azitra Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alpha For further details see: Azitra receives notice of non-...